You are here: Industry Insights > msd

News List

HITGEN AND MSD ENTER Research Collaboration en-cphi
March 22, 2017
Chengdu, China，22nd March, 2017, HitGen Ltd announced that the company has entered into a collaboration with MSD, known as Merck in the United States and Canada, to discover novel chemical leads for multiple therapeutic targets of interest to MSD.
MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial pharmafile
February 28, 2017
MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing the treatment hit its primary endpoint of an improvement in clinically significant cytomegalovirus (CMV) infection following
MSD, Wayra unveil Velocity Health winners pharmatimes
February 23, 2017
Merck Sharp & Dohme (MSD) and Wayra UK have unveiled the 2017 winners of Velocity Health, a ground-breaking preventative digital healthcare accelerator programme designed to address key care challenges.
MSD’s Alzheimer’s drug failure undermines potential treatment pathway pharmafile
February 16, 2017
MSD has announced that it has been forced to cancel a Phase 2/3 trial studying the potential therapeutic effects of verubecestat in Alzheimer’s patients.
Cadila arm acquires six brands from MSD pharma biospectrumasia
January 05, 2017
The deal includes transfer of distribution and commercialisation rights and assignment of trademarks of all the six brands to Zydus Healthcare Limited in India

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page